Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,275
Closed -$176K 85
2023
Q3
$176K Sell
3,275
-211,300
-98% -$11.3M 0.1% 46
2023
Q2
$11.6M Hold
214,575
5.33% 5
2023
Q1
$11.7M Hold
214,575
5.63% 6
2022
Q4
$10.4M Buy
214,575
+525
+0.2% +$23K 4.87% 6
2022
Q3
$8.14M Buy
214,050
+3,300
+2% +$147K 3.76% 12
2022
Q2
$10.5M Buy
210,750
+156,700
+290% +$8.32M 3.71% 8
2022
Q1
$2.77M Buy
+54,050
New +$2.79M 0.86% 30
2021
Q2
Sell
-800
Closed -$40K 157
2021
Q1
$40K Hold
800
0.02% 120
2020
Q4
$39K Hold
800
0.02% 104
2020
Q3
$40K Hold
800
0.02% 102
2020
Q2
$41K Hold
800
0.03% 70
2020
Q1
$35K Hold
800
0.03% 76
2019
Q4
$40K Hold
800
0.03% 81
2019
Q3
$37K Hold
800
0.03% 82
2019
Q2
$35K Hold
800
0.03% 83
2019
Q1
$35K Buy
+800
New +$34.3K 0.02% 85

Other funds holding SNY

NKCFO LLC's SNY Position: Q4 2023 in Review

NKCFO LLC sold out of Sanofi (SNY) in Q4 2023, closing a stake of 3,275 shares — an estimated $176K sold.

NKCFO LLC first reported a position in SNY in Q1 2019 and held it in 16 quarters. The position peaked at $11.7M in Q1 2023. 709 funds tracked by Wall St. Rank hold SNY as of Q4 2023.

  • NKCFO LLC reported no remaining Sanofi position as of Q4 2023 after selling out during the quarter.
  • NKCFO LLC sold 3,275 Sanofi shares in Q4 2023, an estimated $176K.
  • NKCFO LLC first reported a position in Sanofi in Q1 2019 and held it in 16 quarters.
  • NKCFO LLC's Sanofi position peaked at $11.7M in Q1 2023.
  • 709 funds tracked by Wall St. Rank held Sanofi as of Q4 2023.

Based on NKCFO LLC's 13F filing for Q4 2023, filed 6 Feb 2024.